Profile
Lynn Connolly occupies the position of Chief Medical Officer for Adagio Therapeutics, Inc. In her past career she was Senior Medical Director at Achaogen, Inc. and Vice President for Vir Biotechnology, Inc. Dr. Connolly received an undergraduate degree from the University of California, Berkeley and a doctorate from The University of California, San Francisco.
Former positions of Lynn Connolly
| Companies | Position | End |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 24/03/2022 |
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 30/06/2020 |
| ACHAOGEN | Chief Tech/Sci/R&D Officer | 31/12/2016 |
Training of Lynn Connolly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Invivyd, Inc.
Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
- Stock Market
- Insiders
- Lynn Connolly
















